Systemic review and meta-analysis: 10-day or 14-day sequential therapy versus 14-day triple therapy in the first line treatment of Helicobacter pylori infection

被引:0
|
作者
Kuo, Chia-Chi [1 ]
Liou, Jyh-Ming [1 ]
Chen, Chieh-Chang [1 ]
Lee, Yi-Chia [1 ]
Chen, Mei-Jyh [1 ]
Wu, Ming-Shiang [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan
关键词
duration; clarithromycin; metronidazole; resistance; efficacy;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1816
引用
收藏
页码:130 / 130
页数:1
相关论文
共 50 条
  • [21] EFFICACY OF 14-DAY CONCOMITANT THERAPY IN THE ERADICATION OF H. PYLORI INFECTION: COMPARISON WITH 10-DAY CONCOMITANT THERAPY
    Gravina, A. G.
    Zagari, R. M.
    Nardone, G.
    Federico, A.
    Dallio, M.
    Martorano, M.
    Mucherino, C.
    Romiti, A.
    Avallone, L.
    Granata, L.
    Colacino, L.
    Facchiano, A.
    Romito, M. R.
    Tuccillo, C.
    Sgambato, D.
    Miranda, A.
    Loguercio, C.
    Romano, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S76 - S76
  • [22] A Randomized Trial Comparing 14-Day Triple, 10-Day Sequential, and 5-Day Concomitant Therapy to Eradicate Helicobacter pylori in Seven Latin American Populations
    Ferreccio, Catterina
    Anderson, Garnet L.
    Morgan, Douglas R.
    Torres, Javier
    Bravo, Luis Eduardo
    Dominguez, Ricardo
    Herrero, Rolando
    Meza-Montenegro, Mercedes
    Pena, Rodolfo
    Salazar-Martinez, Eduardo
    Chey, William D.
    Valdivieso, Manuel
    Crowley, John
    Goodman, Gary E.
    Greenberg, E. Robert
    Baker, Laurence H.
    GASTROENTEROLOGY, 2011, 140 (05) : S137 - S137
  • [23] Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy
    Sokwala, Ahmed
    Shah, Mahesh V.
    Devani, Smita
    Yonga, Gerald
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (06): : 368 - 371
  • [24] Helicobacter pylori eradication rates with 14-day concomitant therapy vs 10-day concomitant therapy in Greece: Efficacy and safety
    Vrakas, S.
    Koutoufaris, G.
    Ntouli, V.
    Makris, K.
    Milioni, K.
    Kapizioni, C.
    Kourkoulis, P.
    Giannelis, P.
    Xourgia, E.
    Michalopoulos, G.
    Xourgias, V.
    HELICOBACTER, 2017, 22
  • [25] 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
    Greenberg, E. Robert
    Anderson, Garnet L.
    Morgan, Douglas R.
    Torres, Javier
    Chey, William D.
    Eduardo Bravo, Luis
    Dominguez, Ricardo L.
    Ferreccio, Catterina
    Herrero, Rolando
    Lazcano-Ponce, Eduardo C.
    Mercedes Meza-Montenegro, Maria
    Pena, Rodolfo
    Pena, Edgar M.
    Salazar-Martinez, Eduardo
    Correa, Pelayo
    Elena Martinez, Maria
    Valdivieso, Manuel
    Goodman, Gary E.
    Crowley, John J.
    Baker, Laurence H.
    LANCET, 2011, 378 (9790): : 507 - 514
  • [26] Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
    Lee, Seong Tae
    Lee, Dong Ho
    Lim, Ji Hyun
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Jo, Hyun Jin
    Song, In Sung
    GUT AND LIVER, 2015, 9 (04) : 478 - 485
  • [27] 14-Day High Dose Dual Therapy Is Equally As Good As 14-Day Clarithromycin Based Standard Triple Therapy in First Line H.pylori Eradication Treatment
    Leow, Alex Hwong-Ruey
    Chang, Jo-Ven
    Goh, Khean Leen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 259 - 259
  • [28] Search for a Grade a Therapy for Helicobacter pylori Infection: 14-Day Sequential or Sequential-Concomitant Hybrid Therapy
    Hsu, Ping-I
    Wu, Deng-Chyang
    Wu, Jeng-Yih
    Graham, David Y.
    GASTROENTEROLOGY, 2010, 138 (05) : S111 - S111
  • [29] Changing of eradication rate between 7-day and 14-day triple therapy for Helicobacter pylori
    Lee, Si Hyung
    Kim, Kyeong Ok
    Jang, Byung Ik
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 59 - 59
  • [30] 10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial
    Yang, Er -Hsiang
    Chen, Wei-Ying
    Chiang, Hsueh-Chien
    Li, Chung-Hao
    Wu, I-Hsuan
    Chen, Po -Jun
    Wu, Chung -Tai
    Tsai, Yu -Ching
    Cheng, Wei -Chun
    Huang, Chien-Jui
    Sheu, Bor-Shyang
    Cheng, Hsiu-Chi
    ECLINICALMEDICINE, 2024, 70